創薬サービス市場：動向、機会、競合分析【2023年～2028年】

創薬サービス市場の動向と予測

世界の創薬サービス市場は、2023年から2028年までのCAGRが14.1%で、2028年までに推定373億米ドルに達すると予測されています。この市場の主な促進要因は、様々な疾患の症例増加に伴う創薬サービスに対するニーズの高まり、エンドユーザーにおける専門的な検査サービスに対する需要の高まり、未確認薬物の研究活動の活発化です。世界の創薬サービス市場の将来は、製薬・バイオテクノロジー企業や学術機関市場などでのビジネスチャンスが期待できそうです。

創薬サービス企業一覧

市場の企業は、提供する製品の品質に基づいて競争しています。この市場の主要企業は、製造施設の拡大、研究開発投資、インフラ整備、バリューチェーン全体における統合機会の活用に注力しています。これらの戦略により、創薬サービス企業は需要の増加に対応し、競争力を確保し、革新的な製品と技術を開発し、製造コストを削減し、顧客基盤を拡大しています。

創薬サービス市場の洞察

• Lucintelは、低分子のアウトソーシングプロジェクトが増加していること、学術機関、バイオテクノロジー企業、大手製薬企業での採用が増加していることから、予測期間中、化学サービスが最大のセグメントを維持すると予測しています。
• また、高齢者の慢性疾患の増加や、製薬会社やバイオ医薬品会社の新薬開発への関心の高まりから、製薬企業・バイオテクノロジー企業が最大セグメントであり続けると予測されます。
• 北米は、製薬会社やバイオベンチャー企業による研究開発活動への積極的な資金投入、継続的な創薬研究のための高度な設備の利用、主要なCROの存在などにより、予測期間中最大の地域となることが予想されます。

本レポートでは、以下の11の主要な質問に回答しています：

• Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
• Q.2.どの分野がより速いペースで成長するのか、またその理由は？
• Q.3.どの地域がより速いペースで成長すると思うか、またその理由は？
• Q.4.市場力学に影響を与える主要因は何か？この市場における主な課題とビジネスリスクは何か？
• Q.5.この市場におけるビジネスリスクと競合の脅威は何か？
• Q.6.この市場における新たな動向とその理由は何か？
• Q.7.この市場における顧客の要求の変化にはどのようなものがあるか？
• Q.8.市場における新たな開発は何か？これらの開発をリードしているのはどの企業か？
• Q.9.この市場における主要なプレーヤーは誰か？主要プレーヤーは事業成長のためにどのような戦略的取り組みを進めているのか？
• Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替別市場シェア損失の脅威はどの程度あるのか？
• Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の創薬サービス市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の推進力と課題

第3章 2017年から2028年までの市場動向と予測分析

• マクロ経済動向（2017～2022年）と予測（2023～2028年）
• 世界の創薬サービス市場動向（2017-2022）と予測（2023-2028）
• プロセス別の世界の創薬サービス市場
  • ターゲットの選定
  • ターゲットの検証
  • H2Lの識別
  • リードの最適化
  • 候補の検証
• タイプ別の世界の創薬サービス市場
  • 化学サービス
  • 生物学サービス
• 医薬品タイプ別の世界の創薬サービス市場
  • 低分子医薬品
  • バイオ医薬品
• 治療領域別の世界の創薬サービス市場
  • 腫瘍
  • 神経内科
  • 心血管疾患
  • 呼吸器疾患
  • 糖尿病・その他の治療領域
• エンドユーザー別の世界の創薬サービス市場
  • 製薬企業・バイオテクノロジー企業
  • 学術機関
  • その他

第4章 2017年から2028年までの地域別の市場動向と予測分析

• 地域別の創薬サービス市場
• 北米の創薬サービス市場
• 欧州の創薬サービス市場
• アジア太平洋の創薬サービス市場
• その他の地域の創薬サービス市場

第5章 競合分析

• 製品ポートフォリオ分析
• 事業統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • プロセス別の世界の創薬サービス市場の成長機会
  • タイプ別の世界の創薬サービス市場の成長機会
  • 医薬品タイプ別の世界の創薬サービス市場の成長機会
  • 治療領域別の世界の創薬サービス市場の成長機会
  • エンドユーザー別の世界の創薬サービス市場の成長機会
  • 地域別の世界の創薬サービス市場の成長機会
• 世界の創薬サービス市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の創薬サービス市場の能力拡大
  • 世界の創薬サービス市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業プロファイル

• Eurofins Scientific
• Evotec SE
• Charles River Laboratories International
• GenScript
• Thermo Fisher Scientific
• Oncodesign Services
• ChemPartner Co.
• DiscoverX Corp.
• QIAGEN
• Domainex Ltd

Drug Discovery Services Market Trends and Forecast

The future of the global drug discovery services market looks promising with opportunities in the pharmaceutical & biotechnology companies and academic institute markets. The global drug discovery services market is expected to reach an estimated $37.3 billion by 2028 with a CAGR of 14.1% from 2023 to 2028. The major drivers for this market are increasing need for drug discovery services with growing cases of various diseases, growing demand for specialized testing services among end users, and rising research activity on unidentified drugs.

A more than 150-page report is developed to help in your business decisions.

Drug Discovery Services Market by Segment

The study includes a forecast for the global drug discovery services market by process, type, drug type, therapeutic area, end users, and region, as follows:

Drug Discovery Services Market by Process [Value ($B) Shipment Analysis from 2017 to 2028]:

• Target Selection
• Target Validation
• Hit-to-Lead Identification
• Lead Optimization
• Candidate Validation

Drug Discovery Services Market by Type [Value ($B) Shipment Analysis from 2017 to 2028]:

• Chemistry Services
• Biology Services

Drug Discovery Services Market by Drug Type [Value ($B) Shipment Analysis from 2017 to 2028]:

• Small-molecule Drugs
• Biologics

Drug Discovery Services Market by Therapeutic Area [Value ($B) Shipment Analysis from 2017 to 2028]:

• Oncology
• Neurology
• Cardiovascular Diseases
• Respiratory Diseases
• Diabetes and Other Therapeutic Areas

Drug Discovery Services Market by End Users [Value ($B) Shipment Analysis from 2017 to 2028]:

• Pharmaceutical & Biotechnology Companies
• Academic Institutes
• Others

Drug Discovery Services Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Drug Discovery Services Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies drug discovery services companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the drug discovery services companies profiled in this report include.

• Eurofins Scientific
• Evotec SE
• Charles River Laboratories International
• GenScript
• Thermo Fisher Scientific
• Oncodesign Services
• ChemPartner Co.
• DiscoverX Corp.
• QIAGEN
• Domainex Ltd

Drug Discovery Services Market Insights

• Lucintel forecasts that chemistry services will remain the largest segment over the forecast period due to growing number of outsourcing projects for small molecules and increasing adoption in academics, biotechnology companies, and large pharmaceutical companies.
• Within this market, pharmaceutical & biotechnology companies is expected to remain the largest segment due to surge in the number of chronic diseases among the elderly population and growing interest of pharmaceutical and biopharmaceutical companies in developing new drugs.
• North America is expected to remain the largest region during the forecast period due to supportive financial investment in the R&D activities by pharmaceutical and biopharmaceutical companies, availability of advanced equipment for continuous drug discovery research, and presence of key CROs in the region.

Features of the Drug Discovery Services Market

• Market Size Estimates: Drug discovery services market size estimation in terms of value ($B)
• Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
• Segmentation Analysis: Drug discovery services market size by various segments, such as by process, type, drug type, therapeutic area, end users, and region
• Regional Analysis: Drug discovery services market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
• Growth Opportunities: Analysis on growth opportunities in different by process, type, drug type, therapeutic area, end users, and regions for the drug discovery services market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape for the drug discovery services market.
• Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the drug discovery services market size?

Answer: The global drug discovery services market is expected to reach an estimated $37.3 billion by 2028.

Q2. What is the growth forecast for drug discovery services market?

Answer: The global drug discovery services market is expected to grow with a CAGR of 14.1% from 2023 to 2028.

Q3. What are the major drivers influencing the growth of the drug discovery services market?

Answer: The major drivers for this market are increasing need for drug discovery services with augmenting cases of various diseases, growing demand for specialized testing services among end users, and rising research activity on unidentified drugs.

Q4. What are the major segments for drug discovery services market?

Answer: The future of the drug discovery services market looks promising with opportunities in the pharmaceutical & biotechnology companies and academic institute markets.

Q5. Who are the key drug discovery services companies?

Answer: Some of the key drug discovery services companies are as follows:

• Eurofins Scientific
• Evotec SE
• Charles River Laboratories International
• GenScript
• Thermo Fisher Scientific
• Oncodesign Services
• ChemPartner Co.
• DiscoverX Corp.
• QIAGEN
• Domainex Ltd

Q6. Which drug discovery services segment will be the largest in future?

Answer:Lucintel forecasts that chemistry services will remain the largest segment over the forecast period due to growing number of outsourcing projects for small molecules and increasing adoption in academics, biotechnology companies, and large pharmaceutical companies.

Q7. In drug discovery services market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to remain the largest region during the forecast period due to supportive financial investment in the R&D activities by pharmaceutical and biopharmaceutical companies, availability of advanced equipment for continuous drug discovery research, and presence of key CROs in the region.

Q8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions:

• Q.1.What are some of the most promising, high-growth opportunities for the drug discovery services market by process (target selection, target validation, hit-to-lead identification, lead optimization, and candidate validation), type (chemistry services and biology services), drug type (small-molecule drugs and biologics), therapeutic area (oncology, neurology, cardiovascular diseases, respiratory diseases, and diabetes and other therapeutic areas), end users (pharmaceutical & biotechnology companies, academic institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity did occur in the last five years and how did they impact the industry?

Table of Contents

1. Executive Summary

2. Global Drug Discovery Services Market: Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

• 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
• 3.2: Global Drug Discovery Services Market Trends (2017-2022) and Forecast (2023-2028)
• 3.3: Global Drug Discovery Services Market by Process
  • 3.3.1: Target Selection
  • 3.3.2: Target Validation
  • 3.3.3: Hit-to-Lead Identification
  • 3.3.4: Lead Optimization
  • 3.3.5: Candidate Validation
• 3.4: Global Drug Discovery Services Market by Type
  • 3.4.1: Chemistry Services
  • 3.4.2: Biology Services
• 3.5: Global Drug Discovery Services Market by Drug Type
  • 3.5.1: Small-molecule Drugs
  • 3.5.2: Biologics
• 3.6: Global Drug Discovery Services Market by Therapeutic Area
  • 3.6.1: Oncology
  • 3.6.2: Neurology
  • 3.6.3: Cardiovascular Diseases
  • 3.6.4: Respiratory Diseases
  • 3.6.5: Diabetes and Other Therapeutic Areas
• 3.7: Global Drug Discovery Services Market by End Users
  • 3.7.1: Pharmaceutical & Biotechnology Companies
  • 3.7.2: Academic Institutes
  • 3.7.3: Others

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

• 4.1: Drug Discovery Services Market by Region
• 4.2: North American Drug Discovery Services Market
  • 4.2.1: North American Drug Discovery Services Market by Type: Chemistry Services and Biology Services
  • 4.2.2: North American Drug Discovery Services Market by End Users: Pharmaceutical & Biotechnology Companies, Academic Institutes, and Others
• 4.3: European Drug Discovery Services Market
  • 4.3.1: European Drug Discovery Services Market by Type: Chemistry Services and Biology Services
  • 4.3.2: European Drug Discovery Services Market by End Users: Pharmaceutical & Biotechnology Companies, Academic Institutes, and Others
• 4.4: APAC Drug Discovery Services Market
  • 4.4.1: APAC Drug Discovery Services Market by Type: Chemistry Services and Biology Services
  • 4.4.2: APAC Drug Discovery Services Market by End Users: Pharmaceutical & Biotechnology Companies, Academic Institutes, and Others
• 4.5: ROW Drug Discovery Services Market
  • 4.5.1: ROW Drug Discovery Services Market by Type: Chemistry Services and Biology Services
  • 4.5.2: ROW Drug Discovery Services Market by End Users: Pharmaceutical & Biotechnology Companies, Academic Institutes, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Drug Discovery Services Market by Process
  • 6.1.2: Growth Opportunities for the Global Drug Discovery Services Market by Type
  • 6.1.3: Growth Opportunities for the Global Drug Discovery Services Market by Drug Type
  • 6.1.4: Growth Opportunities for the Global Drug Discovery Services Market by Therapeutic Area
  • 6.1.5: Growth Opportunities for the Global Drug Discovery Services Market by End Users
  • 6.1.6: Growth Opportunities for the Global Drug Discovery Services Market by Region
• 6.2: Emerging Trends in the Global Drug Discovery Services Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Drug Discovery Services Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Drug Discovery Services Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Eurofins Scientific
• 7.2: Evotec SE
• 7.3: Charles River Laboratories International
• 7.4: GenScript
• 7.5: Thermo Fisher Scientific
• 7.6: Oncodesign Services
• 7.7: ChemPartner Co.
• 7.8: DiscoverX Corp.
• 7.9: QIAGEN
• 7.10: Domainex Ltd